■原著

1. Kaesmacher J, Mujanovic A, Treurniet K, Kappelhof M, Meinel TR, Yang P, Liu J, Zhang Y, Zi W, Yang Q, Nogueira RG, Kimura K, Matsumaru Y, Suzuki K, Yan B, Mitchell PJ, Miao Z, Roos YBWEM, Majoie CBLM, Gralla J, Saver JL, Fischer U；Perceived acceptable uncertainty regarding comparability of endovascular treatment alone versus intravenous thrombolysis plus endovascular treatment. J Neurointerv Surg. 2023 Mar;15(3):227-232.
2. “Shigeta K, Suzuki K, Matsumaru Y, Takeuchi M, Morimoto M, Kanazawa R, Takayama Y, Kamiya Y, Okubo S, Hayakawa M, Ishii N, Koguchi Y, Ota T, Takigawa T, Inoue M, Naito H, Hirano T, Kato N, Ueda T, Akaji K, Iguchi Y, Miki K, Tsuruta W, Fujimoto S, Enomoto M, Aoyama J, Nakano T, Kimura K；Intravenous Alteplase is Associated with First Pass Effect in Stent-retriever but not ADAPT Thrombectomy : Post Hoc Analysis of the SKIP Study. SKIP study group. Clin Neuroradiol (IF: 3.65; Q2). 2022 Mar;32(1):153-162.
3. Hayashi T, Suda S, Abe A, Iguchi Y, Yagita Y, Kanzawa T, Okubo S, Fujimoto S, Kimura K；PASTA study group. Sustained atrial fibrillation is related to a higher severity of stroke in patients taking direct oral anticoagulants. Journal of the Neurological Sciences:434:120172. (2022)
4. Suda S, Nito C, Ihara M, Iguchi Y, Urabe T, Matsumaru Y, Sakai N, Kimura K；J- REPAIR trial group. Randomised placebo-controlled multicentre trial to evaluate the efficacy and safety of JTR-161, allogeneic human dental pulp stem cells, in patients with Acute Ischaemic stRoke (J-REPAIR). BMJ Open. 2022 May 24;12(5):e054269.
5. Suzuki K, Sugiyama R, Katano T, Shigehara H, Takagiwa T, Katafuchi I, Tanabe M, Ozaki H, Numao S, Aoki J, Nishiyama Y, Kimura K；The safety of rapid administration of enteral nutrition in acute stroke patients. J Neurol Sci (IF: 3.18; Q3). 2022 Jun 15;437:120270.
6. Toshiyuki Hayashi, Shunya Nakane, Akihiro Mukaino, Osamu Higuchi, Makoto Yamakawa, Hidenori Matsuo, Kazumi Kimura；Effectiveness of treatment for 31 patients with seropositive autoimmune autonomic ganglionopathy in Japan. Therapeutic Advances in Neurological Disorders.　15:1-12. (2022)
7. Takehiro Katano, Kentaro Suzuki, Masataka Takeuchi, Masafumi Morimoto , Ryuzaburo Kanazawa 4, Yohei Takayama, Junya Aoki, Yasuhiro Nishiyama, Toshiaki Otsuka, Yuji Matsumaru, Kazumi Kimura；SKIP study Investigators　National Institutes of Health Stroke Scale Score Less Than 10 at 24 hours After Stroke Onset Is a Strong Predictor of a Favorable Outcome After Mechanical Thrombectomy.　Neurosurgery. 91, 936-942. (2022) 
8. Shimoyama T, Yamaguchi H, Kimura K, Suzuki F, Hayashi T, Wakita S. Clinical characteristics and management of headache in patients with myeloproliferative neoplasms. Front Neurol. 2022;13:1051093.
9. Kawano H, Hirano T, Nagao T et al. ；Tenecteplase versus alteplase for large vessel occlusion recanalization (T-FLAVOR): Trial protocol. Eur Stoke J. 2022:7;71-5.
10. Kimura S, Toyoda K, Nagao T et al.；Practical”1-2-3-4-Day”rule for starting direct oral anticoagulants after ischemic stroke with atrial fibrillation : Combined hospital-based cohort study. Stroke. 2022:53:1540-9.
11. Koge J, Yamagami H, Nagao T et al.；Early initiation of rivaroxaban after reperfusion therapy for stroke patients with nonvalvular atrial fibrillation. PLOS ONE. 2022:17;　0264760.
12. Tokunaga K, Yasaka M, Nagao T et al.；Bridging therapy with heparin before starting rivaroxaban in ischemic stroke or transient ischemic attack with non-valvular atrial fibrillation. Circ J. 2022:86:958-63.
13. Shigemoto Y, Matsuda H, Kimura Y, Chiba E, Ohnishi M, Nakaya M, Maikusa N, Ogawa M, Mukai Y, Takahashi Y, Sako K, Toyama H, Inui Y, Taki Y, Nagayama H, Ono K, Kono A, Sekiguchi K, Hirano S, Sato N. Voxel-based analysis of age and gender effects on striatal 123I FP-CIT binding in healthy Japanese adults. Ann Nucl Med. 2022;36(5):460-467.
14. Hatano T, Kano O, Sengoku R, Yoritaka A, Suzuki K, Nishikawa N, Mukai Y, Nomura K, Yoshida N, Seki M, Matsukawa MK, Terashi H, Kimura K, Tashiro J, Hirano S, Murakami H, Joki H, Uchiyama T, Shimura H, Ogaki K, Fukae J, Tsuboi Y, Takahashi K, Yamamoto T, Yanagisawa N, Nagayama H. Evaluating the impact of adjunctive istradefylline on the cumulative dose of levodopa-containing medications in Parkinson’s disease: study protocol for the ISTRA ADJUST PD randomized, controlled study. BMC Neurol. 2022 3;22(1):71.
15. Hokama H, Sakamoto Y, Hayashi T, Hatake S, Takahashi M, Kodera H, Kutsuna A, Nito C, Nakane S, Nagayama H, Takahashi T, Kimura K. FLAMES with Elevated Myelin Basic Protein Followed by Myelitis. Intern Med. 2022;61(23):3585-3588.
16. Komachi T, Saigusa H, Kadosono O, Ito H, Yamaguchi S, Nagayama H, Sakamaki M. A Case of Unilateral Recurrent Nerve Palsy with Chronic Inflammatory Demyelinating Polyradiculoneuropathy. J Nippon Med Sch. 2022;89(5):562-567.

■症例報告

1. 渡邊開斗；歩行障害の増悪で搬送された破傷風の66歳男性例.  臨床神経学. 2022；2(8): 650-650
2. 沓名章仁, 青木淳哉, 古寺紘人, 西山康裕, 中根俊成, 木村和美：Libman-Sacks心内膜炎を合併した中大脳動脈閉塞症に対する機械的血栓回収療法後に遅発性白質病変を認めた1例．臨床神経学．2022；62：716-721
3. Hiroyuki Hokama, Yuki Sakamoto, Toshiyuki Hayashi, Seira Hatake, Mizuho Takahashi, Hiroto Kodera, Akihito Kutsuna, Chikako Nito, Shunya Nakane, Hiroshi Nagayama, Toshiyuki Takahashi, Kazumi Kimura；FLAMES with Elevated Myelin Basic Protein Followed by Myelitis. Internal Medicine. 61, 3585-3588 (2022)

■総説

1. 長尾毅彦：運動障害と感覚障害．日本臨牀 最新臨床脳卒中学　第２版（上） －最新の診断と治療－.　2022; 80 dupp11: 375-380
2. 金丸拓也：無症候性脳血管障害.　無症候性脳出血とmicrobleeds. 日本臨牀 最新臨床脳卒中学　第2版（下） －最新の診断と治療－.　2022；80(増刊2): 489-93.
3. 澤田 和貴, 須田 智, 木村 和美 ：発展する脳卒中診療の最前線 抗凝固療法の最近の動向. 医学のあゆみ. 2022；280(10): 1077-82.
4. Kentaro Suzuki, Kazumi Kimura：Cerebral Infarction with Diffuse and Severe Atherosclerosis of The Main Cerebral Artery and Recurrent Infarction Despite Multiple Antiplatelet Agents: Management for Acute Stroke Patients.　Brain Nerve. 2022 May；74(5):629-636
5. 須田智, 木村和美：ESUS：潜在性心房細動　脳神経内科 特集II．塞栓源不明脳塞栓症（ESUS）を再考する.　97(5) 632-639, 2022
6. Kentaro Suzuki：Let’s Watch the Movie, The Diving Bell and the Butterfly and Think About the Patient’s Feelings. Brain Nerve. 2022 Dec；74(12):1399-1401
7. 須田智, 木村和美：災害・パンデミックと脳卒中　脳神経内科 特集 II．脳卒中と社会背景. 2022；97(4), 521-527